Palbociclib Capsule shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Apr 22, 2026 · last update Apr 22, 2026
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Ibrance, Capsule, 75 mg (NDC 0069-0187-21) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet NDC 0069-0284-03 will continue to be manufactured. | Posted Apr 22, 2026 Updated Apr 22, 2026 Discontinued Apr 22, 2026 |
| Ibrance, Capsule, 100 mg (NDC 0069-0188-21) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured. | Posted Apr 22, 2026 Updated Apr 22, 2026 Discontinued Apr 22, 2026 |